Haidong Shen - Jiangsu Bioperfectus Deputy Center
| 688399 Stock | 76.00 5.49 6.74% |
Executive
Haidong Shen is Deputy Center of Jiangsu Bioperfectus Technologies
| Age | 54 |
| Address | Bioperfectus Technologies Industrial Par, Taizhou, China, 225300 |
| Phone | 86 52 3802 25599 |
| Web | https://www.s-sbio.com |
Jiangsu Bioperfectus Management Efficiency
The company has return on total asset (ROA) of (0.0315) % which means that it has lost $0.0315 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0496) %, meaning that it generated substantial loss on money invested by shareholders. Jiangsu Bioperfectus' management efficiency ratios could be used to measure how well Jiangsu Bioperfectus manages its routine affairs as well as how well it operates its assets and liabilities. At present, Jiangsu Bioperfectus' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 31 M, whereas Total Assets are forecasted to decline to about 2.3 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Hua Zhang | Air China Ltd | 57 | |
| Zhanpeng Chen | Guangzhou Boji Medical | N/A | |
| Yuquan Sun | Air China Ltd | 49 | |
| Yun Li | Air China Ltd | 56 | |
| Jiliang Ni | Air China Ltd | 57 | |
| Chuanyu Xu | Air China Ltd | 60 | |
| Yuping Han | Guangzhou Boji Medical | 51 | |
| Feng Xiao | Air China Ltd | 56 | |
| Chao Huang | CGN Nuclear Technology | 43 | |
| Peicheng Hu | Guangzhou Boji Medical | N/A | |
| Yingnian Wang | Air China Ltd | 61 | |
| Gang Chen | CGN Nuclear Technology | 58 | |
| Simeng Yan | Air China Ltd | 40 | |
| Wang Wang | Nanjing Medlander Medical | 42 | |
| XiaoChuan Li | Guangzhou Boji Medical | N/A | |
| Ho Huen | Air China Ltd | 62 | |
| Bo Qin | CGN Nuclear Technology | 54 | |
| Lian Zuo | Guangzhou Boji Medical | 56 | |
| Yu Han | Guangzhou Boji Medical | 51 | |
| Linghao Yang | CGN Nuclear Technology | 50 | |
| Shaobo Wen | Guangzhou Boji Medical | 41 | |
Management Performance
| Return On Equity | -0.0496 | ||||
| Return On Asset | -0.0315 |
Jiangsu Bioperfectus Leadership Team
Elected by the shareholders, the Jiangsu Bioperfectus' board of directors comprises two types of representatives: Jiangsu Bioperfectus inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jiangsu. The board's role is to monitor Jiangsu Bioperfectus' management team and ensure that shareholders' interests are well served. Jiangsu Bioperfectus' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jiangsu Bioperfectus' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Guoqiang Wang, Chairman GM | ||
| Zhonghua Liu, Technical GM | ||
| Haidong Shen, Deputy Center | ||
| Yuanyuan Hu, Deputy Directors |
Jiangsu Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Jiangsu Bioperfectus a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0496 | ||||
| Return On Asset | -0.0315 | ||||
| Profit Margin | (0.43) % | ||||
| Operating Margin | 0.32 % | ||||
| Current Valuation | 2.56 B | ||||
| Shares Outstanding | 56.67 M | ||||
| Shares Owned By Insiders | 49.47 % | ||||
| Shares Owned By Institutions | 0.60 % | ||||
| Price To Book | 1.31 X | ||||
| Price To Sales | 10.85 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Jiangsu Stock
Jiangsu Bioperfectus financial ratios help investors to determine whether Jiangsu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jiangsu with respect to the benefits of owning Jiangsu Bioperfectus security.